Evrys Bio

Doylestown, United States
Evrys Bio is focused on developing broad-spectrum antiviral therapies.

About Evrys Bio

Evrys Bio is a Healthcare company based in Doylestown (United States). Evrys Bio is focused on developing broad-spectrum antiviral therapies. It operates on a HealthTech model. Evrys Bio offers products and services including SIRT2 Modulator, Pan-Respiratory Antiviral, and Hepatitis Antiviral. Its focus areas include Biotechnology and Antiviral Therapeutics.

Company details

Evrys Bio is engaged in the development of next-generation antiviral therapeutics targeting human sirtuin proteins to enhance natural immunity against viral infections. The company operates in the biotechnology sector, addressing unmet medical needs in infectious diseases. Solutions are designed to combat multiple viruses simultaneously, including hepatitis, respiratory infections, and opportunistic infections in immunosuppressed patients. Their innovative approach aims to overcome drug resistance by leveraging the patients own cellular mechanisms, transforming the treatment landscape for viral diseases with broad-spectrum antiviral products.

  • Headquarters Doylestown, United States
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website forgelifescience.com
Operational Areas

Products & Services of Evrys Bio

Evrys Bio offers a comprehensive portfolio of products and services, including SIRT2 Modulator, Pan-Respiratory Antiviral, and Hepatitis Antiviral.

SIRT2 Modulator
Antiviral Therapy

Broad-spectrum antiviral targeting sirtuins to combat viral infections.

Pan-Respiratory Antiviral
Antiviral Therapy

Antiviral addressing respiratory infections including coronaviruses and influenza.

Hepatitis Antiviral
Antiviral Therapy

Antiviral targeting hepatitis B, C, D, and E viruses.

People of Evrys Bio

39 people are tracked at Evrys Bio (10 in leadership, 24 in board & advisors, 5 in team).

NameRoleGroup
Matthew Todd
Head, Enzymology & BiophysicsLeadership
Lillian W. Chiang
President & CEOLeadership
Susan Little
Head, Human ResourcesLeadership
Dana M Fowlkes
Chief Business OfficerLeadership
Stacy W. Remiszewski
VP, ResearchLeadership
John L. Kulp III
Director, Business DevelopmentLeadership
Steven Ma
Director, OperationsLeadership
Steven Ma Ph.D.
Director Of OperationsLeadership
John Kulp
Director Of Business DevelopmentLeadership
Jens Knudsen
Chief Financial OfficerLeadership
Debra Yu
AdvisorBoard & advisors
Richard J. Whitley
Clinical AdvisorBoard & advisors
Paul Griffiths
Clinical AdvisorBoard & advisors
David Thomas
Clinical AdvisorBoard & advisors
Camille Kotton
Clinical AdvisorBoard & advisors
Michael Boeckh
Clinical AdvisorBoard & advisors
Alan Goldberg
Scientific AdvisorBoard & advisors
Bruce Maryanoff
Scientific AdvisorBoard & advisors
Eric Hanson
Scientific AdvisorBoard & advisors
Tage Honoré
Scientific AdvisorBoard & advisors

19 more people are available in the full profile.

Premium access

Complete people profiles for Evrys Bio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Top companies in Cell Therapy

3 companies that operate in the same segment as Evrys Bio (Cell Therapy) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
2013Seattle, Washington, United StatesUSD 316.67 M520
CAR-T and TIL immunotherapies for solid tumors are developed.
2018San Francisco, California, United StatesUSD 493 MUSD 36 K233
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Evrys Bio

Evrys Bio is headquartered in Doylestown, United States. It is registered at Doylestown, Pennsylvania, United States.

Evrys Bio is engaged in the development of next-generation antiviral therapeutics targeting human sirtuin proteins to enhance natural immunity against viral infections. The company operates in the biotechnology sector, addressing unmet medical needs in infectious diseases. Solutions are designed to combat multiple viruses simultaneously, including hepatitis, respiratory infections, and opportunistic infections in immunosuppressed patients. Their innovative approach aims to overcome drug resistance by leveraging the patients own cellular mechanisms, transforming the treatment landscape for viral diseases with broad-spectrum antiviral products.

Evrys Bio offers SIRT2 Modulator, Pan-Respiratory Antiviral, and Hepatitis Antiviral.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available